FDAnews Drug Daily Bulletin

MDS PHARMA SERVICES DIVESTS FERMENTATION TECHNOLOGIES BUSINESS

Dec. 20, 2005
A A

MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced the sale of its Fermentation Technologies business to Panlabs Biologics of Taiwan, effective today. The move is one of a number of actions taken over the past year to focus the business on its core strengths. The assets associated with the Fermentation business include equipment, technology and personnel located at the MDS Pharma Services facility in Taipei, Taiwan.

Yahoo News (http://biz.yahoo.com/prnews/051219/to018.html?.v=18)